Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-044322
Filing Date
2024-10-30
Accepted
2024-10-30 16:12:44
Documents
58
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cort-20240930.htm   iXBRL 10-Q 966556
2 EX-31.1 cort93024ex311.htm EX-31.1 9435
3 EX-31.2 cort93024ex312.htm EX-31.2 9521
4 EX-32.1 cort93024ex321.htm EX-32.1 5096
5 EX-32.2 cort93024ex322.htm EX-32.2 5022
  Complete submission text file 0001628280-24-044322.txt   4584664

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20240930.xsd EX-101.SCH 30866
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20240930_cal.xml EX-101.CAL 68181
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20240930_def.xml EX-101.DEF 87737
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20240930_lab.xml EX-101.LAB 442137
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20240930_pre.xml EX-101.PRE 280314
61 EXTRACTED XBRL INSTANCE DOCUMENT cort-20240930_htm.xml XML 515127
Mailing Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 241410451
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)